Since resolution WHA72.8 was adopted by Member States in 2019, countries have made efforts and advances in enhancing the availability of information on the markets for health products. Renewed and sustained commitment remains essential if countries are to make progress towards transparency of markets for health products. In addition, in some instances, the ultimate impact of market transparency on availability and affordability remains unknown. To that end, this panel will provide experiences from countries that have endeavored to improve market transparency for health products. Panelists will discuss the processes of setting and implementing a transparency policy agenda in their countries. The aim will be to uncover potential drivers and barriers to success and any early indications of impact on availability and affordability. Such learnings aim to support Member States and all stakeholders in their efforts to achieve and monitor transparency of markets for health products toward improving access.

Session Material:

⬇️ PS1_session_slides_combined

⬇️ PS1_questions_answers_and_links